Skip to content

Management Of Warfarin Coagulopathy For Non-Bleeding Patients In The Outpatient Setting: Overview Of Current Guidelines And Available Evidence

This CE will educate pharmacists on the most up-to-date information on management of supratherapeutic INRs in asymptomatic non-bleeding outpatients on warfarin therapy. Using in-depth discussions of current clinical practice recommendations, review of available data on patient outcomes, and practical discussions, the session will provide learners with knowledge to improve the care and outcomes for outpatients on warfarin therapy who experience asymptomatic supratherapeutic INR levels.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Explain current guideline recommendations on use of Vitamin K in patients on warfarin therapy with supratherapeutic INR levels
  • Compare risk factors that warrant vitamin K use versus no vitamin K use for non-bleeding outpatients with supratherapeutic INR levels due to warfarin therapy


Aaminah Khan, PharmD, is the 2021-2022 MCPHS/Atrius Health PGY-1 pharmacy resident. Aaminah earned her Bachelor of Science in Physiological Science at University of California, Los Angeles followed by her Doctor of Pharmacy at MCPHS in Worcester, MA. Her professional interests include ambulatory and managed care, digital health, and chronic disease management.

Residency Mentor: Kathy Zaiken, PharmD, Professor of Pharmacy Practice

This activity is free of charge.


Release Date: March 16, 2022
Expiration Date: March 16, 2023
ACPE UAN: 0026-0000-22-002-H01-P Knowledge
Topic Designator: Drug Therapy
Contact Hours: 1 (0. 1 CEU)


ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1 contact hour (0.1 CEU).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Aaminah Khan and Kathy Zaiken have no relevant financial relationships with ineligible companies to disclose.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.